Citius Pharmaceuticals (CTXR) Earnings Date & Reports

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CTXR is expected to report earnings to fall 96.06% to -5 cents per share on November 27

Citius Pharmaceuticals CTXR Stock Earnings Reports

Q3'24

Est.

$-0.05

Q1'25

Missed

by $1.31

Q2'24

Missed

by $0.01

Q1'24

Est.

$-0.05

Q4'23

Missed

by $0.19

The last earnings report on May 14 showed earnings per share of -126 cents, missing the estimate of 3 cents. With 26.95K shares outstanding, the current market capitalization sits at 17.10M.

View a ticker or compare two or three

Compare

Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)

Annualized Return+9%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

CTXR